Big Pharma - How much power do drug companies have? | DW Documentary

Summary by Krater

This documentary investigates how major pharmaceutical companies manipulate drug pricing and market strategies, prioritizing profit over public health, with case studies including Daraprim, Dépakine, Avastin, Lucentis, Sovaldi, and Kymriah.

From the video

Answers: How do major pharmaceutical companies manipulate pricing and market systems?

• pharmaceutical industry pricing strategies
• drug price inflation
• market monopolies in healthcare
• side effects of Dépakine
• off-label drug use of Avastin vs Lucentis
• hepatitis C treatment costs of Sovaldi
• CAR-T cell therapy pricing for Kymriah

What it concludes

• Pharmaceutical companies often prioritize shareholder profits over patient health by inflating drug prices beyond defensible levels.
• Major drug manufacturers and laboratories have engaged in off-label marketing and suppressed trial results or alternative treatments to protect high-priced monopoly drugs.
• The cost of drug development and research no longer justifies the extreme prices charged by pharmaceutical companies, which are driven primarily by marketing strategies.